Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: Long-term follow-up

Journal of Clinical Oncology

Volumn 22, Issue 15, 2004, Pages 3061-3069

  Psyrri, Amanda ^a   Kwong, M ^a   DiStasio, S ^a   Lekakis, L ^a   Kassar, M ^a   Sasaki, C ^a   Wilson, L D ^a   Haffty, B G ^a   Son, Y H ^a   Ross, D A ^a   Weinberger, P M ^a   Chung, G G ^a   Zelterman, D ^a   Burtness, B A ^a   Cooper, D L ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; ANTINEOPLASTIC AGENT; PFL PROTOCOL;

ADVANCED CANCER; ARTICLE; BEAM THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPHAGIA; FOLLOW UP; HEAD AND NECK CARCINOMA; HOARSENESS; HUMAN; LASER SURGERY; LONG TERM CARE; MUCOSA INFLAMMATION; NASOPHARYNX TUMOR; NEUTROPENIA; ORGAN PRESERVATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; XEROSTOMIA; ADOLESCENT; ADULT; AGED; BRACHYTHERAPY; DRUG ADMINISTRATION; FEMALE; HEAD AND NECK TUMOR; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PHASE 2 CLINICAL TRIAL; QUALITY OF LIFE; REMISSION; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; QUALITY OF LIFE; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 4143088353     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.01.108     Document Type: Article

References (32)

1. Adjuvant chemotherapy for advanced head and neck squamous carcinoma: Final report of the Head and Neck Contracts Program. Cancer 60:301-311, 1987
2. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer: The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 324:1685-1690, 1991
3. Al-Sarraf M, Pajak TF, Marcial VA, et al: Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck: An RTOG Study. Cancer 59:259-265, 1987
4. Lefebvre JL, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial - EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890-899, 1996
5. Pignon JP, Bourhis J, Domenge C, et al: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data - MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355:949-955, 2000
6. Forastiere AA, Goepfert H, Maor M, et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091-2098, 2003
7. Lo TC, Wiley AL Jr, Ansfield FJ, et al: Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: A randomized study. Am J Roentgenol 126:229-235, 1976
8. Vokes EE, Kies MS, Haraf DJ, et al: Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol 18:1652-1661, 2000
9. Kies MS, Haraf DJ, Rosen F, et al: Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 19:1961-1969, 2001
10. Al-Sarraf M, LeBlanc M, Giri PG, et al: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 16:1310-1317, 1998
11. Al-Sarraf M, Reddy MS: Nasopharyngeal carcinoma. Curr Treat Options Oncol 3:21-32, 2002
12. Dreyfuss AI, Clark JR, Wright JE, et al: Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. Ann Intern Med 112:167-172, 1990
13. Ensley J, Ahmad K, Kish J: Improved response to radiation and concurrent cisplatin in patients with advanced head and neck cancers (SCCHN) that failed induction chemotherapy. Proc Am Soc Clin Oncol 9:1990 (abstr)
14. Marcial VA, Pajak TF, Mohiuddin M, et al: Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck: Long-term results of the Radiation Therapy Oncology Group study 81-17. Cancer 66:1861-1868, 1990
15. Psyrri A, Kwong M, Lekakis L. et al: PFL-induction chemotherapy followed by concomitant cisplatin chemoradiotherapy (CRT) for head and neck squamous cell cancer (HNSCC): Long-term follow-up. Proc Am Soc Clin Oncol 22:500, 2003 (abstr 2014)
16. Harrison LB, Pfister DG, Fass DE, et al: Concomitant chemotherapy- radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer. Int J Radiat Oncol Biol Phys 21:703-708, 1991
17. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
18. List MA, D'Antonio LL, Cella DF, et al: The performance status scale for head and neck cancer patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale: A study of utility and validity. Cancer 77:2294-2301, 1996
19. List MA, Ritter-Sterr C, Lansky SB: A performance status scale for head and neck cancer patients. Cancer 66:564-569, 1990
20. Warren S, Gates O: Multiple primary malignant tumors: A survey of the literature and statistical study. Am J Cancer 51:1358, 1932
21. Karim AB, Kralendonk JH, Njo KH, et al: Radiation therapy for advanced (T3T4N0-N3M0) laryngeal carcinoma: The need for a change of strategy - A radiotherapeutic viewpoint. Int J Radiat Oncol Biol Phys 13:1625-1633, 1987
22. Vermund H, Boysen M, Brandenburg JH, et al: Primary irradiation, surgery or combined therapy in squamous cell carcinoma of the larynx: A comparison of treatment results from two centers. Acta Oncol 29:489-503, 1990
23. McLean M: Primary management of limited laryngeal cancer by radiotherapy and surgical salvage: Results of 164 cases treated in a district hospital. Clin Oncol (R Coll Radiol) 1:97-100, 1989
24. Hill BT, Price LA, MacRae K: Importance of primary site in assessing chemotherapy response and 7-year survival data in advanced squamous-cell carcinomas of the head and neck treated with initial combination chemotherapy without cisplatin. J Clin Oncol 4:1340-1347, 1986
25. Vokes EE, Schilsky RL, Weichselbaum RR, et al: Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer. Cancer 63:1048-1053, 1989
26. Clark JR, Busse PM, Norris CM Jr, et al: Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: Long-term results. J Clin Oncol 15:3100-3110, 1997
27. Vokes EE, Stenson K, Rosen FR, et al: Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: Curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 21:320-326, 2003
28. Spector JG, Sessions DG, Haughey BH, et al: Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope 111:1079-1087, 2001
29. Spector GJ: Distant metastases from laryngeal and hypopharyngeal cancer. ORL J Otorhinolaryngol Relat Spec 63:224-228, 2001
30. Leon X, Quer M, Orus C, et al: Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck 22:680-686, 2000
31. Schwartz DL, Rajendran J, Yueh B, et al: Staging of head and neck squamous cell cancer with extended-field FDG-PET. Arch Otolaryngol Head Neck Surg 129:1173-1178, 2003
32. Antoch G, Vogt FM, Freudenberg LS, et al: Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290:3199-3206, 2003